Friday, November 9, 2018
Morning
07:00 a.m. - 08:00 a.m.
Location: Americana Ballroom Salon 1&2
SMSNA Business Meeting (members only) - Including Breakfast
08:00 a.m. - 09:00 a.m.
Location: Americana Ballroom Salon 3
ISSM Session
Moderator: Luiz Otavio Torres, MD
08:00 a.m. - 08:05 a.m.
Introduction to ISSM and WMSM 2020
Speakers: Luiz Otavio Torres, MD & Yoshikazu Sato, MD, PhD
08:05 a.m. - 08:25 a.m.
The Best of the 21st World Meeting on Sexual Medicine 2018
Speaker: Wayne Hellstrom, MD
08:25 a.m. - 08:45 a.m.
What is Hot and What's Not in Female Sexual Medicine: Separating Fact from Fiction
Speaker: Michael Krychman, MD
08:45 a.m. - 09:00 a.m.
Use and Abuse of Testosterone and other Steroids: What do we know?
Speaker: Luiz Otavio Torres, MD
09:00 a.m. - 10:00 a.m.
Location: Americana Ballroom Salon 3
ESSM Session: What's New in MSD Treatment? The European Perspective
Moderators: Hartmut Porst, MD & Yacov Reisman, MD
09:00 a.m. - 09:15 a.m.
Pro & Con of Low-Intensity Shockwave therapy (LISWT) for Erectile Dysfunction
Speaker: Yacov Reisman, MD
09:15 a.m. - 09:30 a.m.
New Developments in Premature Ejaculation Treatment
Speaker: Ege Can Serefoglu, MD
09:30 a.m. - 09:45 a.m.
News on Peyronie's Disease
Speaker: Carlo Bettocchi, MD
09:45 a.m. - 09:55 a.m.
ESSM Future Activities
Speaker: Yacov Reisman, MD
09:55 a.m. - 10:00 a.m.
Q&A
10:00 a.m. - 10:30 a.m.
Location: Americana Ballroom Salon 4
Coffee Break
10:05 a.m. - 10:30 a.m.
Location: Americana Ballroom Foyer - E-Poster Station 1
E-Poster Session 6 - Female Sexual Dysfunction/Miscellaneous 2
Moderator: Sherita King, MD
10:05 a.m. - 10:08 a.m.
Bremelanotide for Hypoactive Sexual Desire Disorder: Age and Weight Subgroup Efficacy Analyses (RECONNECT Studies) (#215)
Speaker: Anita Clayton
10:08 a.m. - 10:11 a.m.
Vaginal Diazepam to Treat Pelvic Floor Pain (#216)
Speaker: Alexandra Berger
10:11 a.m. - 10:14 a.m.
Pilates Exercise for Treatment of Female Sexual Dysfunction (#217)
Speaker: Ahmet Gokce, MD
10:14 a.m. - 10:17 a.m.
The Efficacy of Vaginal Moisturizers Composed of β-glucans in Treatment of Vulvo-vaginal Atrophy with Post-menopausal Women (#218)
Speaker: Sun Tae Ahn, MD
10:17 a.m. - 10:20 a.m.
Female Residents are as Successful as Male Counterparts in Discussions Leading to Penile Implant Surgery (#219)
Speaker: Andrew Kramer, MD
10:20 a.m. - 10:23 a.m.
SEXpertise - Approach to Sexual Health in the Medical Consultation Setting (#220)
Speaker: Carla Rodrigues
10:23 a.m. - 10:26 a.m.
A Very Rare Tumor of the Spermatic Cord Found During an Infertility Consultation: The Malignant Fibrous Histiocytoma (#221)
Speaker: Andreas Bannowsky
10:05 a.m. - 10:30 a.m.
Location: Americana Ballroom Foyer - E-Poster Station 2
E-Poster Session 7 - Erectile Dysfunction Surgical 3
Moderator: Charles Welliver, MD
10:05 a.m. - 10:08 a.m.
Safety Tab: A Novel Approach to Intraoperative Inflatable Penile Prosthesis (IPP) Cylinder Resizing (#222)
Speaker: Joseph Sarcona
10:08 a.m. - 10:11 a.m.
Penile Prosthesis Salvage with Saline or Antibiotic Solutions: A Review of the Different Irrigation Solutions, their Rational, and Effects in Wound Healing (#223)
Speaker: Dayron Rodríguez
10:11 a.m. - 10:14 a.m.
Surgeons should not Fear Performing Additional Urologic Procedures at the Time of Penile Prosthesis Implantation (#224)
Speaker: Jeffrey D. Campbell
10:14 a.m. - 10:17 a.m.
Inflatable Penile Prosthesis in the Ambulatory Surgical Setting: Outcomes from a Large Urological Group Practice (#225)
Speaker: Aaron Weinberg
10:17 a.m. - 10:20 a.m.
Determine Penile Oxygen Saturation and Blood Gases after Vacuum Erectile Device like Important Factor in Penile Rehabilitation (#226)
Speaker: Sergey Kotov
10:20 a.m. - 10:23 a.m.
Penile Rehabilitation after Nerve-sparing Radical Prostatectomy (#227)
Speaker: Sergei Kotov
10:23 a.m. - 10:26 a.m.
Developing a Catalog of Non-infectious Distal Cylinder Complications Requiring Revision Penile Implant Surgery (#228)
Speaker: Bruce Kava, MD
10:26 a.m. - 10:29 a.m.
Sexual Satisfaction and Ease of Use Influences Overall Inflatable Penile Prosthesis Patient Satisfaction (#229)
Speaker: Daniel Nassau
10:05 a.m. - 10:30 a.m.
Location: Americana Ballroom Foyer - E-Poster Station 3
E-Poster Session 8 - Androgens/Steroids
Moderator: Faysal Yafi, MD, FRCSC
10:05 a.m. - 10:08 a.m.
Glucose, Glycated Hemoglobin A Levels and Erectile Function in 16 Hypogonadal Men with Type 2 Diabetes (T2DM) Before and After Testosterone Therapy (#230)
Speaker: Karim Sultan Haider
10:08 a.m. - 10:11 a.m.
Natesto Effects on Reproductive Hormones and Semen Parameters: Results from an ongoing Single Center Investigator-initiated Phase IV Clinical Trial (#231)
Speaker: Thomas Masterson
10:11 a.m. - 10:14 a.m.
Effects of Androgen Replacement Therapy and Once-a-day Tadalafil on Loss of Vigor & Energy (LOVE) Syndrome in Men’s Health Clinic (#232)
Speaker: Yoshikazu Sato, MD, PhD
10:14 a.m. - 10:17 a.m.
Human Chorionic Gonadotropin (hCG) Monotherapy for the Treatment of Symptoms of Hypogonadism in Men with Total Testosterone > 300 ng/Dl (#233)
Speaker: Vinayak Madhusoodanan
10:17 a.m. - 10:20 a.m.
Testosterone-Replacement Therapy in Patients with Baseline Low-normal to Normal Testosterone Levels and Hypogonadal Symptoms (#234)
Speaker: Nelson Bennett, MD, FACS
10:20 a.m. - 10:23 a.m.
Can a Dietary Supplement Support Sperm Motility and Sperm Quality? (#235)
Speaker: Michael Krychman, MD
10:23 a.m. - 10:26 a.m.
Long-standing Diabetes and Poor Glycemic Control Result in Worse Peyronie's Curvature (#236)
Speaker: Dorota Hawksworth
10:30 a.m. - 12:00 p.m.
Location: Poinciana 1&2
Mental Health Session: Towards a Transdisciplinary Approach to Sexual Medicine and Sexual Health: Addressing Sexual Problems from a Biopsychosocial Perspective
Moderators: Michael Perelman, PhD & Daniela Wittmann, PhD, LMSW
10:30 a.m. - 10:40 a.m.
Updates in Mental Health - Most Noteworthy Literature from 2017-2018
Speaker: Chiara Acquati, PhD, MSW
10:40 a.m. - 10:50 a.m.
Addressing Sexual Health after Spinal Cord Injury: The Sexual Rehabilitation Framework
Speaker: Stacy Elliott, MD
10:50 a.m. - 11:00 a.m.
The Impact of Infertility on Sexuality
Speaker: Elizabeth Grill, PhD
11:00 a.m. - 11:10 a.m.
The Impact of Sexual Dysfunction on Relationships (#007)
Speaker: Jack Andrews
11:10 a.m. - 11:20 a.m.
Motivational Interviewing for Sexual Health Risky Behaviors (#008)
Speaker: Carla Rodrigues
11:20 a.m. - 11:30 a.m.
Double Stigma: Masculinity Meets Sexual Dysfunction in Chronic Illness
Speaker: Andrew Matthew, PhD
11:30 a.m. - 11:40 a.m.
When to Refer Urology, Andrology and Gynecology Patients to Sexual Health or Mental Health Providers?
Speaker: Annamaria Giraldi, MD, PhD
11:40 a.m. - 11:50 a.m.
The Impact of Pelvic Pain on Sexuality
Speaker: Melissa Farmer, PhD
11:50 a.m. - 12:00 p.m.
Q&A
10:30 a.m. - 12:00 p.m.
Location: Americana Ballroom Salon 3
Male Sexual Dysfunction
Moderators: Arthur Burnett II, MD & Doron Stember, MD
10:30 a.m. - 10:40 a.m.
Updates in Male Sexual Health - Most Noteworthy Literature from 2017-2018
Speaker: Casey McCraw, MD
10:40 a.m. - 10:55 a.m.
A Treatment Algorithm for Healthy Young Men with Erectile Dysfunction
Speaker: Laurence Levine, MD
10:55 a.m. - 11:10 a.m.
Crossing the Intersection Between Men's Sexual Health and Men's Health
Speaker: Bruce Kava, MD
11:10 a.m. - 11:30 a.m.
Q&A
11:30 a.m. - 12:00 p.m.
5th Annual Robert Krane Lecture: From the Nitric Oxide/cGMP Pathway and gene/PDE5i Therapy, to Stem Cells in Sexual Medicine Research: A Glimpse on an Ongoing Journey
Speaker: Nestor Gonzalez-Cadavid, PhD
10:30 a.m. - 12:00 p.m.
Location: Poinciana 3&4
Transgender
Moderators: Maurice Garcia, MD, MAS & Stanton Honig, MD
10:30 a.m. - 10:40 a.m.
Updates in Transgender Medicine - Most Noteworthy Literature from 2017-2018
Speaker: Dmitriy Nikolavsky, MD
10:40 a.m. - 10:50 a.m.
Feminizing Genital Gender Affirming Surgery and Sexual Function: Vaginoplasty with Creation of a Vaginal Canal and Without Creation of a Vaginal Canal
Speaker: Stanton Honig, MD
10:50 a.m. - 11:00 a.m.
Feminizing Genital Gender Affirming Surgery and Sexual Function: Strategies to Optimize the Hospital Pathway
Speaker: Polina Reyblat, MD
11:00 a.m. - 11:10 a.m.
There’s More to Surgery than a Steady Hand: Patient Reported Outcomes in Gender Affirming Surgery (#009)
Speaker: Alexandra Millman
11:10 a.m. - 11:20 a.m.
A Novel Pre-surgery Counseling Aid for Transgender Patients Undergoing MtoF Genital Gender Affirming Surgery with Vaginoplasty to Help Manage Patient Expectations and to Facilitate Patient’s Choice of Surgery (Full-Depth or Shallow-Depth Vaginoplasty) (#010)
Speaker: Maurice Garcia, MD, MAS
11:20 a.m. - 11:30 a.m.
Masculinizing Genital Gender Affirming Surgery and Sexual Function: Phallourethroplasty Using Radial Artery Forearm Flap and Anterior Lateral Thigh Flap Techniques: Strategies to Optimize Sexual Function and Common Urinary Tract Complications
Speaker: Maurice Garcia, MD, MAS
11:30 a.m. - 11:40 a.m.
Masculinizing Genital Gender Affirming Surgery and Sexual Function: Metoidioplasty with and without Urethral Lengthening
Speaker: Ervin Kocjancic, MD
11:40 a.m. - 11:55 a.m.
Strategies to Good Clinical Outcomes by Optimizing Proper Patient Selection and Management of Surgery Related Expectations: Lessons Learned from the Mental Health Professional and from Surgical Management
Speaker: Maurice Garcia, MD, MAS
11:55 a.m. - 12:00 p.m.
Q&A
Afternoon
12:00 p.m. - 01:30 p.m.
Location: Americana Ballroom Salon 1&2
Industry Sponsored Lunch Symposium
01:30 p.m. - 02:30 p.m.
Location: Americana Ballroom Salon 3
Female Sexual Dysfunction
Moderators: Tami Rowen, MD, MS, FACOG & Maureen Whelihan, MD, FACOG
01:30 p.m. - 01:40 p.m.
Updates in Female Sexual Dysfunction - Most Noteworthy Literature from 2017-2018
Speaker: Seth Cohen, MD, MPH
01:40 p.m. - 01:50 p.m.
Process of Care for Management of Women with HSDD
Speaker: Irwin Goldstein, MD
01:50 p.m. - 02:00 p.m.
Kissing, Cuddling, and Massage at Most Recent Sexual Event: Findings from a U.S. Nationally Representative Probability Sample (#011)
Speaker: Tsung-Chieh Fu
02:00 p.m. - 02:10 p.m.
Lasers and Lubricants: Which Ones are Best for my Practice and my Patients?
Speaker: Ashley Tapscott, DO
02:10 p.m. - 02:20 p.m.
What's HOT in Female Sexual Dysfunction
Speaker: Michael Krychman, MD
02:20 p.m. - 02:30 p.m.
Q&A
01:30 p.m. - 03:30 p.m.
Location: Poinciana 1&2
Peyronie's Disease - Moderated Posters
Moderators: Bruce Kava, MD & Hartmut Porst, MD
01:50 p.m. - 01:55 p.m.
Peyronie’s Disease Pictorial Intake Form - A Novel Tool for Evaluating Penile Curvature (#105)
Speaker: Mohamed Adnan
01:55 p.m. - 02:00 p.m.
Cost Effectiveness of Peyronie’s Disease Therapies: A Comparison of RestoreX Penile Traction Therapy, Collagenase Clostridium Histolyticum, and Surgery (#106)
Speaker: Kevin Wymer
02:00 p.m. - 02:05 p.m.
Efficacy of Combined Xiaflex and RestoreX Penile Traction Therapy in Men with Peyronie’s Disease (#107)
Speaker: Manaf Alom
02:05 p.m. - 02:10 p.m.
Intralesional Collagenase Clostridium Histolyticum Causes Meaningful Improvement in Men with Peyronie’s Disease: The Results of a Multi-institutional Analysis (#108)
Speaker: Hoang Minh Tue Nguyen
02:10 p.m. - 02:15 p.m.
Penile Plication For Severe Peyronie's Deformities Has Similar Patient Reported Outcomes To Mild Cases (#109)
Speaker: Michael Davenport
02:15 p.m. - 02:20 p.m.
Safety and Efficacy of Collagenase Clostridium Histolyticum in Peyronie’s Disease Men with Ventral Curvatures (#110)
Speaker: Manaf Alom
02:20 p.m. - 02:25 p.m.
Long-term Safety and Curvature Deformity Characterization in Patients Previously Treated with Collagenase Clostridium Histolyticum for Peyronie’s Disease (#111)
Speaker: Irwin Goldstein, MD
02:25 p.m. - 03:30 p.m.
Adherence to Xiaflex (collagenase clostridium histolyticum) Label Recommendations and Provider Satisfaction: A Survey of ISSM Members (#112)
Speaker: Alex Galante
02:30 p.m. - 02:35 p.m.
Long-term Complete Outcomes of Concurrent Tachosil Grafting with Inflatable Penile Prosthesis Placement (#113)
Speaker: Joshua Ring
02:35 p.m. - 02:40 p.m.
The Impact of Intralesional Xiaflex On Psychosocial Outcomes in Men with Peyronie’s Disease (PD) (#114)
Speaker: Bruno Nascimento
02:40 p.m. - 02:45 p.m.
Incision and Buccal Mucosa Grafting in the Treatment of Peyronie's Disease (#115)
Speaker: Sergei Kotov
02:45 p.m. - 02:50 p.m.
Evaluation of Complication Rates Related to Surgical Management of Concurrent Erectile Dysfunction and Peyronie’s Disease: National Multi-institutional Analysis of the National Surgical Quality Improvement Program (NSQIP) Database (#116)
Speaker: Mahmoud Khalil
02:50 p.m. - 02:55 p.m.
The Effect of Adjunct Mechanical Traction on Penile Length in Men Undergoing Primary Treatment for Peyronie's Disease: A Systematic Review and Meta-analysis (#117)
Speaker: Nora Haney
02:55 p.m. - 03:00 p.m.
Rates of Completion and Reasons for Dropout from a Standard Eight-Injection Course of Collagenase Clostridium Histolyticum Therapy (#118)
Speaker: Arash Amighi
01:30 p.m. - 03:30 p.m.
Location: Poinciana 3&4
Androgens - Moderated Posters
Moderators: Abraham Morgentaler, MD & Cigdem (Cori) Tanrikut, MD
01:50 p.m. - 01:55 p.m.
Staying Above Water: The Impact of Testosterone and Growth Hormone Secretagogues on Fluid Retention Parameters (#119)
Speaker: Alexander J. Tatem
01:55 p.m. - 02:00 p.m.
Effect of Testosterone Enanthate on 24-hour Ambulatory Blood Pressure is Less in Patients with Hypertension at Baseline (#120)
Speaker: Mohit Khera, MD
02:00 p.m. - 02:05 p.m.
Efficacy and Safety of a Mixed Extract of Trigonella foenum-graecum Seed and Lespedeza cuneata in the Treatment of Testosterone Deficiency Syndrome: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial (#121)
Speaker: Nam Cheol Park
02:05 p.m. - 02:10 p.m.
Diagnosis and Management of Testosterone Deficiency – Comparison of Current Guidelines (#122)
Speaker: Yonah Krakowsky
02:10 p.m. - 02:15 p.m.
Total Testosterone Level and Infiltrating Lymphocyte Density within the Prostate: Is There an Optimal Window? (#123)
Speaker: Andrew Gabrielson
02:15 p.m. - 02:20 p.m.
Failure of Testosterone Replacement Therapy to Improve Symptoms Correlates with Burden of Systemic Conditions (#124)
Speaker: Sarah Vij
02:20 p.m. - 02:25 p.m.
The Relationship Between PSA and Total Testosterone Levels in Men with Low, Intermediate and High Grade Prostate Cancer (#125)
Speaker: Helen Levey Bernie, DO, MPH
02:25 p.m. - 02:30 p.m.
Testosterone Imposters: An Analysis of Popular Online Testosterone Boosting Supplements (#126)
Speaker: Adithya Balasubramanian
02:30 p.m. - 02:35 p.m.
Misinformation of Testosterone Replacement on the Internet (#127)
Speaker: Denise Asafu-Adjei
02:35 p.m. - 02:40 p.m.
Treatment of Estrogen Levels in the Management of Hypogonadism: An Anonymous Survey of ISSM Members (#128)
Speaker: Nannan Thirumavalavan, MD, BA
02:40 p.m. - 02:45 p.m.
Treatment of Hypogonadism in the Solid Organ Transplant Recipient: A Case Series from a High-volume Andrology Clinic (#129)
Speaker: Nannan Thirumavalavan, MD, BA
02:45 p.m. - 02:50 p.m.
Toremifene Citrate Improves High-Density Lipoprotein Levels in Men on Testosterone Replacement Therapy (#130)
Speaker: Alexander J. Tatem
02:50 p.m. - 02:55 p.m.
Differences in Androgen Levels and Sexual Function between North American and European Men (#131)
Speaker: Mahmoud Mima
02:55 p.m. - 03:00 p.m.
Erectile and Urinary Function and Quality of Life Improve in Hypogonadal Men with Osteoporosis Under Long-Term Testosterone Therapy with Testosterone Undecanoate Injections (TU) in Comparison to an Untreated Control Group: 10-Year Data from a Registry Study in a Urological Setting (#132)
Speaker: Ahmad Haider
03:00 p.m. - 03:05 p.m.
Larger Than Life: Motivations for Bodybuilding and Anabolic Steroid Usage (#133)
Speaker: Jonathan Beilan
03:05 p.m. - 03:10 p.m.
Impaired Sleep is Associated with Low Testosterone in US Adult Males: Results from the National Health and Nutrition Examination Survey (#134)
Speaker: Premal Patel, MD
03:10 p.m. - 03:15 p.m.
Reference Intervals for Serum Testosterone Levels in Korean: Results from Large Health Examination Data (#135)
Speaker: Myong Kim
03:15 p.m. - 03:20 p.m.
Cross-sectional Association Between Testosterone and Metabolic Syndrome (#136)
Speaker: Yu Seob Shin
02:30 p.m. - 03:30 p.m.
Location: Americana Ballroom Salon 3
Erectile Dysfunction - Medical
Moderators: Tobias Kohler, MD, MPH; Mustafa Usta, MD & Run Wang, MD, FACS
02:30 p.m. - 02:40 p.m.
Updates in Erectile Dysfunction (Medical) - Most Noteworthy Literature from 2017-2018
Speaker: Helen Levey Bernie, DO, MPH
02:40 p.m. - 02:55 p.m.
How to Conduct and Interpret Duplex Doppler Ultrasonography in Med with ED
Speaker: Gerald Brock, MD
02:55 p.m. - 03:05 p.m.
Alternative ED Therapies - LiSWT, PRP, Stem Cells: Advancement in the Era of Regulation
Speaker: Gregory Broderick, MD
03:05 p.m. - 03:15 p.m.
Vibrator Stimulation: Is There a Role for ED?
Speaker: Serge Carrier, MD
03:15 p.m. - 03:30 p.m.
AUA Erectile Dysfunction Guidelines
Speaker: Hossein Sadeghi-Nejad, MD, FACS
03:30 p.m. - 04:00 p.m.
Location: Americana Ballroom Salon 4
Coffee Break
03:35 p.m. - 04:00 p.m.
Location: Americana Ballroom Foyer - E-Poster Station 1
E-Poster Session 9 - Erectile Dysfunction Surgical 4
Moderator: Billy Cordon, MD
03:35 p.m. - 03:38 p.m.
Bibliometric Analysis of Erectile Dysfunction Publications in Urology and Sexual Medicine Journals (#237)
Speaker: Martin Gross, MD
03:38 p.m. - 03:41 p.m.
Grumpy Old Men? The Association Between Age and Satisfaction in Men Undergoing Placement of Inflatable Penile Prostheses (#238)
Speaker: Adam Miller
03:41 p.m. - 03:44 p.m.
Addition of Multiple Hemostatic Agents Improves Hematoma Formation and Outcomes in Penile Implant Surgery (#239)
Speaker: Andrew Kramer, MD
03:44 p.m. - 03:47 p.m.
Film Study and Comprehensive Video Analysis to Improve Surgical Technique with Specific Outcome Metrics (#240)
Speaker: Andrew Kramer, MD
03:47 p.m. - 03:50 p.m.
Simulation Training in Prosthetic Urology: Cadaveric Laboratory Training Improves Trainees’ Surgical Confidence and Knowledge (#241)
Speaker: Dayron Rodriguez
03:50 p.m. - 03:53 p.m.
Commercial Insurance Coverage for Inflatable Penile Prosthesis at a Tertiary Care Center (#242)
Speaker: John Masterson
03:53 p.m. - 03:56 p.m.
Closed Suction Drain Outputs at 12 and 24 Hours After Primary Three-piece Inflatable Penile Prosthesis Surgery (#244)
Speaker: Dayron Rodriquez
03:35 p.m. - 04:00 p.m.
Location: Americana Ballroom Foyer - E-Poster Station 2
E-Poster Session 10 - Urinary/BPH/Incontinence 1
Moderator: Amy Pearlman, MD
03:35 p.m. - 03:38 p.m.
Rezūm Prostate Ablation for Large Gland (≥80 grams) Prostates (#245)
Speaker: Ross Avant
03:38 p.m. - 03:41 p.m.
Urethral Bulking at Time of Artificial Urinary Sphincter Implantation (#246)
Speaker: Dorota Hawksworth
03:41 p.m. - 03:44 p.m.
Comparison of Complication Rates Related to Penile Prosthesis and Advance™ Male Slings Versus Penile Prosthesis and Artificial Urinary Sphincters: National Multi‑institutional Analysis of NSQIP Database (#247)
Speaker: Omer Raheem
03:44 p.m. - 03:47 p.m.
Single-incision Urethral Closure and Penile Prosthesis Removal (#248)
Speaker: Jonathan Beilan
03:47 p.m. - 03:50 p.m.
Efficacy and Safety of Holmium Laser Enucleation of Prostate (HoLEP) in Patients with Underlying Neurologic Disease (#249)
Speaker: Myong Kim
03:50 p.m. - 03:53 p.m.
Single Perineal Incision for Artificial Urinary Sphincter: An Analysis of Technique, Outcomes, and Experience (#250)
Speaker: Nahid Punjani
03:35 p.m. - 04:00 p.m.
Location: Americana Ballroom Foyer - E-Poster Station 3
E-Poster Session 11 - Urinary/BPH/Incontinence 2
Moderator: Ashley Tapscott, DO
03:35 p.m. - 03:38 p.m.
Search for a Rational Supplement Combination for Prostatism and Erectile Dysfunction (#251)
Speaker: Robert Pyke
03:38 p.m. - 03:41 p.m.
Is Sexual Function Better Preserved After Water Vapor Thermal Therapy or Medical Therapy For Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia? (#252)
Speaker: Nikhil Gupta
03:41 p.m. - 03:44 p.m.
Descriptive Outcomes of Patients Undergoing UroLift for Extended Indications (#253)
Speaker: Jacob Jipp
03:44 p.m. - 03:47 p.m.
A Prospective Evaluation of Diabetic Patients Receiving Inflatable Penile Prosthesis (#254)
Speaker: Alfredo Suarez-Sarmiento
03:47 p.m. - 03:50 p.m.
Long-term Outcomes of Permanent Urethral Ligation (PUL) for Men with Recurrent Artificial Urinary Sphincter (AUS) Erosion (#255)
Speaker: Ryan Baker
03:50 p.m. - 03:53 p.m.
A Novel Prostatic Block for Minimally Invasive Treatment for BPH (#256)
Speaker: Joel Hillelsohn
03:53 p.m. - 03:56 p.m.
Use of a Suprapubic Tube at the Time of Artificial Urinary Sphincter Placement: A Strategy to Avoid Urethral Catheterization in the “At Risk” Patient (#257)
Speaker: Christopher Graziano, MD
04:00 p.m. - 05:30 p.m.
Location: Americana Ballroom Salon 3
Androgens
Moderators: Serge Carrier, MD; Jason Jameson, MD & Hui Jiang, MD
04:00 p.m. - 04:10 p.m.
Updates in Androgens - Most Noteworthy Literature from 2017-2018
Speaker: Anand Shridharani, MD
04:10 p.m. - 04:20 p.m.
Controversies in Testosterone Therapies: What Have We Learned from the Testosterone Trials
Speaker: Mohit Khera, MD
04:20 p.m. - 04:30 p.m.
Incidence and Characteristics of Men at High Risk for Sleep Apnea in a High Volume Andrology Clinic (#012)
Speaker: Alexander J. Tatem
04:30 p.m. - 04:40 p.m.
Mortality, Incident Myocardial Infarction and Stroke in Hypogonadal Men with a Pre-existing Cardiovascular Disease With and Without Testosterone Therapy: Real-life Evidence from a 10-Year Registry (#013)
Speaker: Karim Sultan Haider
04:40 p.m. - 04:55 p.m.
How to Treat Low Testosterone: Identification, Lab Testing, Medication Choice, Follow-up
Speaker: Martin Miner, MD
04:55 p.m. - 05:05 p.m.
Debate: Should Testosterone Therapy Only Be Used in Classical Hypogonadism: PRO
Speaker: Lawrence Jenkins, MD, MBA
05:05 p.m. - 05:15 p.m.
Debate: Should Testosterone Therapy Only Be Used in Classical Hypogonadism: CON
Speaker: Kelly Chiles, MD
05:15 p.m. - 05:30 p.m.
AUA Testosterone Guidelines
Speaker: Landon Trost, MD
04:00 p.m. - 05:30 p.m.
Location: Poinciana 1&2
Female Sexual Dysfunction - Moderated Posters
Moderators: Don S. Dizon, MD & Sherita King, MD
04:15 p.m. - 04:20 p.m.
Three-site Prospective Double-blind, Sham-controlled Pilot Study to Examine the Safety and Efficacy of CO2 Fractional Laser Therapy to the Vestibule in Women with Distress from Vestibulodynia: Interim Analysis of Vulvoscopic Photographic Images (#137)
Speaker: Irwin Goldstein, MD
04:20 p.m. - 04:25 p.m.
Bremelanotide for Hypoactive Sexual Desire Disorder in the RECONNECT Study: Analysis of Co-primary Endpoints According to Baseline FSFI Total Scores (#138)
Speaker: Anita Clayton
04:25 p.m. - 04:30 p.m.
Effects of Alcohol Administered with Flibanserin in Healthy Premenopausal Women: A Randomized, Double-Blind, Single-Dose, Seven-way Crossover Study (#139)
Speaker: James Simon
04:30 p.m. - 04:35 p.m.
The Impact of the Timing of Alcohol Consumption on the Safety and Tolerability of Flibanserin (#140)
Speaker: James Simon
04:35 p.m. - 04:40 p.m.
"If Everyone Else is Having This Talk with Their Doctor, Why am I Not Having This Talk with Mine?": The Experiences of Sexuality and Sexual Health Education of Young Women with Spina Bifida (#141)
Speaker: Christine Schafer
04:40 p.m. - 04:45 p.m.
Evaluation of Sexual Functions of Female Patients Using Systemic Retinoid for Acne Vulgaris Treatment (#142)
Speaker: Mehmet Gokhan Culha
04:45 p.m. - 04:50 p.m.
Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate Efficacy and Safety of Ospemifene in Patients with Moderate to Severe Vaginal Dryness, Including Evaluation of Vulvar Health by Photographic Images (#143)
Speaker: Irwin Goldstein, MD
04:50 p.m. - 04:55 p.m.
Safety of Flibanserin in Women with Hypoactive Sexual Desire Disorder Taking Antidepressant Medications (#144)
Speaker: Anita Clayton
04:55 p.m. - 05:00 p.m.
Low Rates of Insomnia Associated with Flibanserin in Premenopausal Women with Hypoactive Sexual Desire Disorder (#145)
Speaker: Sharon Parish. MD, NCMP
05:00 p.m. - 05:05 p.m.
Conversations with Participants in the RECONNECT Studies About Their Experiences With Bremelanotide for Treatment of Hypoactive Sexual Desire Disorder (#146)
Speaker: Robin Pokrzywinsiki
05:05 p.m. - 05:10 p.m.
Premature Ejaculation and Female Sexual Dysfunction (#147)
Speaker: Ahmet Gokce, MD
05:10 p.m. - 05:15 p.m.
Evaluation of Female Sexual Dysfunction in Adult Entertainers (#148)
Speaker: Justin Dubin
05:15 p.m. - 05:20 p.m.
Would Ultra-low-dose Trazodone Treat HSDD Without Causing CNS Depression? (#149)
Speaker: Robert Pyke
05:20 p.m. - 05:25 p.m.
Sexual Dysfunction and Distress in Premenopausal Women with Migraine: Association with Depression, Anxiety and Migraine Related Disability (#150)
Speaker: Sefa Resim
05:25 p.m. - 05:30 p.m.
Milli™; the Only Patient Controlled Expanding Dilator: Results from the Initial Launch (#151)
Speaker: Michael Krychman, MD
04:00 p.m. - 05:30 p.m.
Location: Poinciana 3&4
Erectile Dysfunction (Medical) - Moderated Posters
Moderators: Seth Cohen, MD, MPH & Haocheng Lin, MD
04:10 p.m. - 04:15 p.m.
Variability in Cash Prices for Erectile Dysfunction Medications – Are All Pharmacies the Same? (#152)
Speaker: Kirtishri Mishra
04:15 p.m. - 04:20 p.m.
Preliminary Assessment on the Treatment of Erectile Dysfunction with Bimix Gel (#153)
Speaker: Daniel Martinez
04:20 p.m. - 04:25 p.m.
Is Statin Use at Time of Prostate Cancer Radiation Associated with Protection of Patient-reported Erectile Function? (#154)
Speaker: Bridget Koontz
04:25 p.m. - 04:30 p.m.
Pharmacokinetics of MED2005, a Topical Glyceryl Trinitrate Gel for the Treatment of Erectile Dysfunction (#155)
Speaker: Tim Holland
04:30 p.m. - 04:35 p.m.
Development of Nomograms to Predict Erectile Function After Radiation Therapy (#156)
Speaker: Helen Levey Bernie, DO, MPH
04:35 p.m. - 04:40 p.m.
Rethinking Prosthetic Solutions to Erectile Dysfunction (#157)
Speaker: Claire Apuan
04:40 p.m. - 04:45 p.m.
Penile Rehabilitation in the Long-term Follow-up – How Important is the Preservation of Nocturnal Penile Tumescense with Daily Low-dose Sildenafil 6 Weeks after Nerve-sparing Radical Prostatectomy? (#158)
Speaker: Andreas Bannowsky
04:45 p.m. - 04:50 p.m.
Two-year Cost Analysis of Penile Rehabilitation Post-prostatectomy for Various Regimens at a Single Institution (#159)
Speaker: Nelson Bennett, MD, FACS
04:50 p.m. - 04:55 p.m.
Predictors of Worsening Erectile Function in Men with Functional Erections Early After Radical Prostatectomy (#160)
Speaker: Helen Levey Bernie, DO, MPH
04:55 p.m. - 05:00 p.m.
A Phase II Randomized Trial to Evaluate Different Dose Regimens of Low-intensity Extracorporeal Shock Wave Therapy for Erectile Dysfunction (#161)
Speaker: Jonathan Katz
05:00 p.m. - 05:05 p.m.
Use of Radial Pulse Therapy and Nitric Oxide Boosting Supplement in the Treatment of ED (#162)
Speaker: Judson Brandeis
05:05 p.m. - 05:10 p.m.
Adherence and Outcomes with Penile Rehabilitation over a 2 Year Period (#163)
Speaker: Jeffrey Albaugh, PhD, APRN, CUCNS
05:10 p.m. - 05:15 p.m.
Generic Forms of Sildenafil Citrate Contain Impurities with Reduced or Absent Phosphodiesterase Type-5 (PDE5) Inhibition: A Global Survey (#164)
Speaker: Samuel Sherratt
05:15 p.m. - 05:20 p.m.
Impact of Penile Traction Therapy on Erectile Dysfunction in a Cohort of Men with Peyronie's Disease (#165)
Speaker: David Yang
05:20 p.m. - 05:25 p.m.
Analysis of Popular Erectile Dysfunction Supplements on Amazon.com (#166)
Speaker: Adithya Balasubramanian
05:25 p.m. - 05:30 p.m.
Improvement in SHIM Scores with the iNOS Stimulator, Revactin® (#167)
Speaker: Jacob Rajfer
Evening
05:30 p.m. - 06:30 p.m.
Location: Cowrie
Young Clinicians Mixer